PICKERING, ON, April 6, 2016 /CNW/ – Purdue Pharma Canada is disappointed by the decision and subsequent statement issued by Health Canada on April 4th, 2016 to not proceed with the proposed regulations requiring tamper resistance for oxycodone. We continue to believe products…